KR100608963B1 - 프로필렌 글리콜 및 이소프로필 알칸산 에스테르를포함하는 항바이러스 제제 - Google Patents

프로필렌 글리콜 및 이소프로필 알칸산 에스테르를포함하는 항바이러스 제제 Download PDF

Info

Publication number
KR100608963B1
KR100608963B1 KR1020017006232A KR20017006232A KR100608963B1 KR 100608963 B1 KR100608963 B1 KR 100608963B1 KR 1020017006232 A KR1020017006232 A KR 1020017006232A KR 20017006232 A KR20017006232 A KR 20017006232A KR 100608963 B1 KR100608963 B1 KR 100608963B1
Authority
KR
South Korea
Prior art keywords
composition
weight
propylene glycol
isopropyl
alkanoic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020017006232A
Other languages
English (en)
Korean (ko)
Other versions
KR20010075720A (ko
Inventor
구닐라 레케어
Original Assignee
메디비르 아베
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20413320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR100608963(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 메디비르 아베 filed Critical 메디비르 아베
Publication of KR20010075720A publication Critical patent/KR20010075720A/ko
Application granted granted Critical
Publication of KR100608963B1 publication Critical patent/KR100608963B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020017006232A 1998-11-18 1999-11-12 프로필렌 글리콜 및 이소프로필 알칸산 에스테르를포함하는 항바이러스 제제 Expired - Fee Related KR100608963B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9803929-0 1998-11-18
SE9803929A SE9803929D0 (sv) 1998-11-18 1998-11-18 Antiviral formulation

Publications (2)

Publication Number Publication Date
KR20010075720A KR20010075720A (ko) 2001-08-09
KR100608963B1 true KR100608963B1 (ko) 2006-08-09

Family

ID=20413320

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017006232A Expired - Fee Related KR100608963B1 (ko) 1998-11-18 1999-11-12 프로필렌 글리콜 및 이소프로필 알칸산 에스테르를포함하는 항바이러스 제제

Country Status (21)

Country Link
EP (1) EP1131104B1 (enExample)
JP (2) JP2002529520A (enExample)
KR (1) KR100608963B1 (enExample)
CN (1) CN1160128C (enExample)
AR (1) AR023705A1 (enExample)
AT (1) ATE288283T1 (enExample)
AU (1) AU772435B2 (enExample)
CA (1) CA2351463C (enExample)
DE (1) DE69923584T2 (enExample)
DK (1) DK1131104T3 (enExample)
EG (1) EG23853A (enExample)
ES (1) ES2233104T3 (enExample)
HK (1) HK1042440B (enExample)
IL (2) IL142702A0 (enExample)
MY (1) MY122397A (enExample)
NZ (1) NZ511832A (enExample)
PT (1) PT1131104E (enExample)
SE (1) SE9803929D0 (enExample)
TW (1) TW589191B (enExample)
WO (1) WO2000029027A1 (enExample)
ZA (1) ZA200103335B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100956369B1 (ko) * 2001-11-19 2010-05-10 메디진 아게 바이러스성 피부 질환 및 종양 질환 치료용 약제
ZA200602544B (en) 2003-10-09 2007-06-27 Medigene Ag The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin
JP4972062B2 (ja) * 2008-03-17 2012-07-11 メディヴィル・アクチエボラーグ 抗ウイルス製剤
ES2955089T3 (es) * 2018-08-17 2023-11-28 Ilko Ilac Sanayi Ve Ticaret Anonim Sirketi Composición tópica estable en fase que comprende aciclovir e hidrocortisona

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438585B (en) * 1995-02-06 2001-06-07 Astra Ab Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
US5760096A (en) * 1996-10-18 1998-06-02 Thornfeldt; Carl R. Potent penetration enhancers

Also Published As

Publication number Publication date
HK1042440A1 (en) 2002-08-16
EG23853A (en) 2007-11-06
AU1436400A (en) 2000-06-05
AU772435B2 (en) 2004-04-29
TW589191B (en) 2004-06-01
CN1326364A (zh) 2001-12-12
DK1131104T3 (da) 2005-03-14
ES2233104T3 (es) 2005-06-01
IL142702A (en) 2006-07-05
HK1042440B (zh) 2005-04-29
EP1131104B1 (en) 2005-02-02
ZA200103335B (en) 2002-07-24
MY122397A (en) 2006-04-29
NZ511832A (en) 2003-09-26
ATE288283T1 (de) 2005-02-15
CN1160128C (zh) 2004-08-04
CA2351463C (en) 2009-10-13
DE69923584T2 (de) 2006-03-23
JP2002529520A (ja) 2002-09-10
IL142702A0 (en) 2002-03-10
KR20010075720A (ko) 2001-08-09
PT1131104E (pt) 2005-03-31
EP1131104A1 (en) 2001-09-12
WO2000029027A1 (en) 2000-05-25
JP5420583B2 (ja) 2014-02-19
SE9803929D0 (sv) 1998-11-18
CA2351463A1 (en) 2000-05-25
AR023705A1 (es) 2002-09-04
JP2011157392A (ja) 2011-08-18
DE69923584D1 (de) 2005-03-10

Similar Documents

Publication Publication Date Title
US20170020882A1 (en) Antiviral formulation
US7223387B2 (en) Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
JP5420583B2 (ja) プロピレングリコールおよびアルカン酸イソプロピルエステルを含む抗ウイルス製剤
EP1140117B1 (en) Aciclovir compositions containing dimethicone
EP3836934B1 (en) Phase stable topical composition comprising acyclovir and hydrocortisone
MXPA01005020A (en) Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
SA99200836B1 (ar) صيغ مضادة للفيروسات antiviral formulations تتضمن propylene glycol واستر أيزويروبيلي لحمض الكانوي isopropyl alkanoic acid ester
MXPA01006490A (en) Aciclovir compositions containing dimethicone
TR2021002170T2 (tr) Faz ayrişmasi olmayan asi̇klovi̇r ve hi̇drokorti̇zon i̇çeren topi̇kal formülasyon

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

FPAY Annual fee payment

Payment date: 20130712

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

FPAY Annual fee payment

Payment date: 20140702

Year of fee payment: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

FPAY Annual fee payment

Payment date: 20150702

Year of fee payment: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

FPAY Annual fee payment

Payment date: 20160711

Year of fee payment: 11

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

J206 Request for trial to confirm the scope of a patent right
PJ0206 Trial to confirm the scope of a patent

St.27 status event code: A-5-5-V10-V11-apl-PJ0206

J301 Trial decision

Free format text: TRIAL NUMBER: 2016100002999; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20160928

Effective date: 20170424

PJ1301 Trial decision

St.27 status event code: A-5-5-V10-V15-crt-PJ1301

Decision date: 20170424

Appeal event data comment text: Appeal Kind Category : Confirmation of the scope of right_defensive, Appeal Ground Text : 0608963

Appeal request date: 20160928

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2016100002999

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 12

PJ0206 Trial to confirm the scope of a patent

St.27 status event code: A-5-5-V10-V11-apl-PJ0206

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 13

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

J301 Trial decision

Free format text: TRIAL NUMBER: 2017100002785; TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20170831

Effective date: 20190722

PJ1301 Trial decision

St.27 status event code: A-5-5-V10-V15-crt-PJ1301

Decision date: 20190722

Appeal event data comment text: Appeal Kind Category : Confirmation of the scope of right_defensive, Appeal Ground Text : 0608963

Appeal request date: 20170831

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2017100002785

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20190728

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20190728